Close Menu

NEW YORK (360Dx) – Finnish life sciences firm Olfactomics is developing an ion mobility-based system for assessing margins during cancer surgery, but which may have diagnostic use eventually.

The company is developing its own ion mobility device for this purpose, which it hopes to have completed in 2019, said Antti Roine, Olfactomics' founder and a surgeon and cancer researcher at the University of Tampere.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.